Michael Colvin
Overview
Explore the profile of Michael Colvin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ivey M, Colvin M, Strickland B, Lashley M
Ecol Evol
. 2019 Jul;
9(13):7761-7767.
PMID: 31346438
Biological invasions often have contrasting consequences with reports of invasions decreasing diversity at small scales and facilitating diversity at large scales. Thus, previous literature has concluded that invasions have a...
2.
Shen X, Connolly T, Huang Y, Colvin M, Wang C, Lu J
Macromol Rapid Commun
. 2016 May;
37(23):1904-1911.
PMID: 27191677
A low-energy triggered switch that can generate mechanoresponse has great technological potential. A submolecular moiety, S-dibenzocyclooctadiene (DBCOD) that is composed of a flexible eight-membered ring connecting to a phenyl ring...
3.
Ando D, Zandi R, Kim Y, Colvin M, Rexach M, Gopinathan A
Biophys J
. 2014 May;
106(9):1997-2007.
PMID: 24806932
The transport of cargo across the nuclear membrane is highly selective and accomplished by a poorly understood mechanism involving hundreds of nucleoporins lining the inside of the nuclear pore complex...
4.
Ando D, Colvin M, Rexach M, Gopinathan A
PLoS One
. 2013 Sep;
8(9):e73831.
PMID: 24066078
Bioinformatics of disordered proteins is especially challenging given high mutation rates for homologous proteins and that functionality may not be strongly related to sequence. Here we have performed a novel...
5.
6.
Bacolod M, Fehdrau R, Johnson S, Bullock N, Bigner D, Colvin M, et al.
Cancer Chemother Pharmacol
. 2008 Jul;
63(4):753-8.
PMID: 18633619
Purpose: Resistance of neoplastic cells to the alkylating drug BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea] has been correlated with expression of O (6)-methylguanine-DNA methyltransferase, which repairs the O (6)-chloroethylguanine produced by the drug. Other...
7.
Chute J, Muramoto G, Whitesides J, Colvin M, Safi R, Chao N, et al.
Proc Natl Acad Sci U S A
. 2006 Jul;
103(31):11707-12.
PMID: 16857736
Aldehyde dehydrogenase (ALDH) is an enzyme that is expressed in the liver and is required for the conversion of retinol (vitamin A) to retinoic acids. ALDH is also highly enriched...
8.
Adams D, Wahl M, Flowers J, Sen B, Colvin M, Dewhirst M, et al.
Cancer Chemother Pharmacol
. 2005 Jul;
57(2):145-54.
PMID: 16001167
Human breast tumors often exist in an acidic and hypoxic microenvironment, which can promote resistance to radiation and chemotherapies. A tumor-selective pH gradient arises in these tumors which favors uptake...
9.
Colvin M, McGuire W, Fowlie P
BMJ
. 2004 Dec;
329(7479):1390-3.
PMID: 15591566
No abstract available.
10.
Duan X, Zhou Z, Jia S, Colvin M, LaFleur E, Kleinerman E
Clin Cancer Res
. 2004 Feb;
10(2):777-83.
PMID: 14760101
Cyclophosphamide (CY) and its derivative ifosfamide are alkylating agents used to treat osteosarcoma (OS). The purpose of these studies was to determine whether alkylating agents affect the expression of Fas...